{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:22:36Z","timestamp":1793910156653,"version":"4.8.0"},"reference-count":141,"publisher":"European Respiratory Society (ERS)","issue":"174","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2024,10,11]]},"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:p>The Epithelial Science Expert Group convened on 18\u201319 October 2023, in Naples, Italy, to discuss the current understanding of the fundamental role of the airway epithelium in asthma and other respiratory diseases and to explore the future direction of patient care. This review summarises the key concepts and research questions that were raised. As an introduction to the epithelial era of research, the evolution of asthma management throughout the ages was discussed and the role of the epithelium as an immune-functioning organ was elucidated. The role of the bronchial epithelial cells in lower airway diseases beyond severe asthma was considered, as well as the role of the epithelium in upper airway diseases such as chronic rhinosinusitis. The biology and application of biomarkers in patient care was also discussed. The Epithelial Science Expert Group also explored future research needs by identifying the current knowledge and research gaps in asthma management and ranking them by priority. It was identified that there is a need to define and support early assessment of asthma to characterise patients at high risk of severe asthma. Furthermore, a better understanding of asthma progression is required. The development of new treatments and diagnostic tests as well as the identification of new biomarkers will also be required to address the current unmet needs. Finally, an increased understanding of epithelial dysfunction will determine if we can alter disease progression and achieve clinical remission.<\/jats:p>","DOI":"10.1183\/16000617.0221-2024","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T10:25:53Z","timestamp":1734517553000},"page":"240221","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["The epithelial era of asthma research: knowledge gaps and future direction for patient care"],"prefix":"10.1183","volume":"33","author":[{"given":"Christopher E.","family":"Brightling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Marone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Aegerter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4059-0917","authenticated-orcid":false,"given":"Pascal","family":"Chanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Heffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian D.","family":"Pavord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus F.","family":"Rabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Uller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Del","family":"Dorscheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Epithelial Science Expert Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"2024121802253982000_33.174.240221.1","unstructured":"Asthma.net . History of asthma (part one): in the beginning. Date last accessed: 10 November 2023. Date last updated: 10 July 2017. https:\/\/asthma.net\/living\/history-of-asthma-part-one-in-the-beginning"},{"key":"2024121802253982000_33.174.240221.2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0081-2021"},{"key":"2024121802253982000_33.174.240221.3","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1918.00090150111007"},{"key":"2024121802253982000_33.174.240221.4","first-page":"803","article-title":"CONTROLLED trial of effects of cortisone acetate in status asthmaticus","volume":"271","year":"1956","journal-title":"Lancet"},{"key":"2024121802253982000_33.174.240221.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(58)91385-0"},{"key":"2024121802253982000_33.174.240221.6","doi-asserted-by":"crossref","first-page":"840","DOI":"10.4049\/jimmunol.97.6.840","article-title":"Physicochemical properties of reaginic antibody. V. Correlation of reaginic activity with gamma-E-globulin antibody","volume":"97","author":"Ishizaka","year":"1966","journal-title":"J Immunol"},{"key":"2024121802253982000_33.174.240221.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5800.585"},{"key":"2024121802253982000_33.174.240221.8","first-page":"439","article-title":"A look at the pathogenesis of asthma: the need for a change in direction","volume":"9","author":"Holgate","year":"2010","journal-title":"Discov Med"},{"key":"2024121802253982000_33.174.240221.9","doi-asserted-by":"publisher","DOI":"10.1084\/jem.2042fta"},{"key":"2024121802253982000_33.174.240221.10","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.93.06101507"},{"key":"2024121802253982000_33.174.240221.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1992.tb02064.x"},{"key":"2024121802253982000_33.174.240221.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)01813-9"},{"key":"2024121802253982000_33.174.240221.13","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.3.9812110"},{"key":"2024121802253982000_33.174.240221.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.10.041"},{"key":"2024121802253982000_33.174.240221.15","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200711-1754OC"},{"key":"2024121802253982000_33.174.240221.16","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200903-0392OC"},{"key":"2024121802253982000_33.174.240221.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808991"},{"key":"2024121802253982000_33.174.240221.18","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12880"},{"key":"2024121802253982000_33.174.240221.19","doi-asserted-by":"publisher","DOI":"10.1164\/RCCM.202104-1040LE"},{"key":"2024121802253982000_33.174.240221.20","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01397-2023"},{"key":"2024121802253982000_33.174.240221.21","doi-asserted-by":"crossref","first-page":"8901","DOI":"10.3390\/ijms21238907","article-title":"The airway epithelium\u2014a central player in asthma pathogenesis","volume":"21","author":"Calv\u00e9n","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2024121802253982000_33.174.240221.22","doi-asserted-by":"publisher","DOI":"10.1111\/all.14421"},{"key":"2024121802253982000_33.174.240221.23","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI124606","article-title":"Epithelial cell-derived cytokines: more than just signaling the alarm","volume":"129","author":"Roan","year":"2019","journal-title":"J Clin Invest"},{"key":"2024121802253982000_33.174.240221.24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01595"},{"key":"2024121802253982000_33.174.240221.25","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-020-00370-7"},{"key":"2024121802253982000_33.174.240221.26","doi-asserted-by":"crossref","first-page":"e1367458","DOI":"10.1080\/21688370.2017.1367458","article-title":"Airway epithelial barrier dysfunction in the pathogenesis and prognosis of respiratory tract diseases in childhood and adulthood","volume":"5","author":"Yuksel","year":"2017","journal-title":"Tissue Barriers"},{"key":"2024121802253982000_33.174.240221.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00477-9"},{"key":"2024121802253982000_33.174.240221.28","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200907-067DP"},{"key":"2024121802253982000_33.174.240221.29","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00141514"},{"key":"2024121802253982000_33.174.240221.30","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01619-2023"},{"key":"2024121802253982000_33.174.240221.31","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20112691"},{"key":"2024121802253982000_33.174.240221.32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31500-8"},{"key":"2024121802253982000_33.174.240221.33","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.720227"},{"key":"2024121802253982000_33.174.240221.34","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00014-10"},{"key":"2024121802253982000_33.174.240221.35","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00149009"},{"key":"2024121802253982000_33.174.240221.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61380-3"},{"key":"2024121802253982000_33.174.240221.37","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.125930"},{"key":"2024121802253982000_33.174.240221.38","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.3389\/fimmu.2019.02765","article-title":"Oxidative stress attenuates TLR3 responsiveness and impairs anti-viral mechanisms in bronchial epithelial cells from COPD and asthma patients","volume":"10","author":"Menzel","year":"2019","journal-title":"Front Immunol"},{"key":"2024121802253982000_33.174.240221.39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12865-021-00424-w","article-title":"Direct effects of mast cell proteases, tryptase and chymase, on bronchial epithelial integrity proteins and anti-viral responses","volume":"22","author":"Ramu","year":"2021","journal-title":"BMC Immunol"},{"key":"2024121802253982000_33.174.240221.40","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/all.13378","article-title":"House dust mite impairs antiviral response in asthma exacerbation models through its effects on TLR3","volume":"73","author":"Akbarshahi","year":"2018","journal-title":"Allergy"},{"key":"2024121802253982000_33.174.240221.41","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1111\/all.15243","article-title":"House dust mite sensitization and exposure affects bronchial epithelial anti-microbial response to viral stimuli in patients with asthma","volume":"77","author":"Cerps","year":"2022","journal-title":"Allergy"},{"key":"2024121802253982000_33.174.240221.42","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1164\/rccm.202209-1708OC","article-title":"Allergen immunotherapy enhances airway epithelial antiviral immunity in patients with allergic asthma (VITAL study): a double-blind randomized controlled trial","volume":"207","author":"Woehlk","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2024121802253982000_33.174.240221.43","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01824-2014"},{"key":"2024121802253982000_33.174.240221.44","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.mucimm.2023.07.003","article-title":"Airway epithelium IgE-Fc\u03b5RI cross-link induces epithelial barrier disruption in severe T2-high asthma","volume":"16","author":"Weng","year":"2023","journal-title":"Mucosal Immunol"},{"key":"2024121802253982000_33.174.240221.45","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12016-018-8712-1","article-title":"Understanding asthma phenotypes, endotypes, and mechanisms of disease","volume":"56","author":"Kuruvilla","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"2024121802253982000_33.174.240221.46","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02333-2021"},{"key":"2024121802253982000_33.174.240221.47","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.jaci.2017.04.005","article-title":"Phenotypic and genetic aspects of epithelial barrier function in asthmatic patients","volume":"139","author":"Loxham","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2024121802253982000_33.174.240221.48","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin15.376"},{"key":"2024121802253982000_33.174.240221.49","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0144-2022"},{"key":"2024121802253982000_33.174.240221.50","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13223-017-0219-4","article-title":"Asthma biomarkers in the age of biologics","volume":"13","author":"Kim","year":"2017","journal-title":"Allergy Asthma Clin Immunol"},{"key":"2024121802253982000_33.174.240221.51","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00260-2020"},{"key":"2024121802253982000_33.174.240221.52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024257"},{"key":"2024121802253982000_33.174.240221.53","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S2213-2600(21)00556-7","article-title":"Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial","volume":"10","author":"Yousuf","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2024121802253982000_33.174.240221.54","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2147\/JAA.S275039","article-title":"Targeting TSLP in asthma","volume":"15","author":"Parnes","year":"2022","journal-title":"J Asthma Allergy"},{"key":"2024121802253982000_33.174.240221.55","doi-asserted-by":"crossref","first-page":"2101296","DOI":"10.1183\/13993003.01296-2021","article-title":"The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM)","volume":"59","author":"Sverrild","year":"2022","journal-title":"Eur Respir J"},{"key":"2024121802253982000_33.174.240221.56","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/all.15918","article-title":"Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma","volume":"79","author":"Sverrild","year":"2024","journal-title":"Allergy"},{"key":"2024121802253982000_33.174.240221.57","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1111\/all.15473","article-title":"Biologics and airway remodeling in severe asthma","volume":"77","author":"Varricchi","year":"2022","journal-title":"Allergy"},{"key":"2024121802253982000_33.174.240221.58","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/318029"},{"key":"2024121802253982000_33.174.240221.59","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.supplement_2.2106066"},{"key":"2024121802253982000_33.174.240221.60","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e32831da8d3"},{"key":"2024121802253982000_33.174.240221.61","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.rmed.2017.12.013","article-title":"Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations","volume":"135","author":"Mart\u00ednez-Rivera","year":"2018","journal-title":"Respir Med"},{"key":"2024121802253982000_33.174.240221.62","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2003.018879"},{"key":"2024121802253982000_33.174.240221.63","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pathol-042220-015902","article-title":"The pathology of asthma: what is obstructing our view?","volume":"18","author":"Aegerter","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"2024121802253982000_33.174.240221.64","doi-asserted-by":"publisher","DOI":"10.1172\/JCI95693"},{"key":"2024121802253982000_33.174.240221.65","doi-asserted-by":"crossref","first-page":"309","DOI":"10.47162\/RJME.61.2.01","article-title":"Latest advances in chronic rhinosinusitis with nasal polyps endotyping and biomarkers, and their significance for daily practice","volume":"61","author":"Maniu","year":"2020","journal-title":"Rom J Morphol Embryol"},{"key":"2024121802253982000_33.174.240221.66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087681"},{"key":"2024121802253982000_33.174.240221.67","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12931-019-1245-1","article-title":"Upregulation of MUC5AC by VEGF in human primary bronchial epithelial cells: implications for asthma","volume":"20","author":"Kim","year":"2019","journal-title":"Respir Res"},{"key":"2024121802253982000_33.174.240221.68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2104490118"},{"key":"2024121802253982000_33.174.240221.69","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.3390\/jcm8111955","article-title":"Mucins and asthma: are we headed to the revolutionary road?","volume":"8","author":"Santus","year":"2019","journal-title":"J Clin Med"},{"key":"2024121802253982000_33.174.240221.70","doi-asserted-by":"publisher","DOI":"10.2500\/ajra.2014.28.4018"},{"key":"2024121802253982000_33.174.240221.71","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/JLB.3AB0220-311R","article-title":"Galectin-10, the protein that forms Charcot\u2013Leyden crystals, is not stored in granules but resides in the peripheral cytoplasm of human eosinophils","volume":"108","author":"Melo","year":"2020","journal-title":"J Leukoc Biol"},{"key":"2024121802253982000_33.174.240221.72","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-842260"},{"key":"2024121802253982000_33.174.240221.73","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw4295"},{"key":"2024121802253982000_33.174.240221.74","doi-asserted-by":"crossref","first-page":"EVIDoa2300135","DOI":"10.1056\/EVIDoa2300135","article-title":"Tezepelumab and mucus plugs in patients with moderate-to-severe asthma","volume":"2","author":"Nordenmark","year":"2023","journal-title":"NEJM Evidence"},{"key":"2024121802253982000_33.174.240221.75","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.chest.2023.02.009","article-title":"CT mucus score and 129Xe MRI ventilation defects after 2.5-years\u2019 anti-IL-5R\u03b1 in eosinophilic asthma","volume":"164","author":"McIntosh","year":"2023","journal-title":"Chest"},{"key":"2024121802253982000_33.174.240221.76","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1164\/rccm.202306-1102LE","article-title":"Effects of dupilumab on mucus plugging and ventilation defects in patients with moderate-to-severe asthma: a randomized, double-blind, placebo-controlled trial","volume":"208","author":"Svenningsen","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2024121802253982000_33.174.240221.77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2011.03917.x"},{"key":"2024121802253982000_33.174.240221.78","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200209-1030OC"},{"key":"2024121802253982000_33.174.240221.79","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4168\/aair.2022.14.2.196","article-title":"Mucus plugs and small airway dysfunction in asthma, COPD, and asthma\u2013COPD overlap","volume":"14","author":"Tamura","year":"2022","journal-title":"Allergy Asthma Immunol Res"},{"key":"2024121802253982000_33.174.240221.80","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jaci.2016.02.001","article-title":"Relationship between lung function and quantitative computed tomographic parameters of airway remodeling, air trapping, and emphysema in patients with asthma and chronic obstructive pulmonary disease: a single-center study","volume":"137","author":"Hartley","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2024121802253982000_33.174.240221.81","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/01902148.2018.1536175","article-title":"TSLP promotes asthmatic airway remodeling via p38-STAT3 signaling pathway in human lung fibroblast","volume":"44","author":"Cao","year":"2018","journal-title":"Exp Lung Res"},{"key":"2024121802253982000_33.174.240221.82","doi-asserted-by":"publisher","DOI":"10.3109\/02770903.2014.921196"},{"key":"2024121802253982000_33.174.240221.83","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1177\/1535370219843827","article-title":"IL-25 contributes to lung fibrosis by directly acting on alveolar epithelial cells and fibroblasts","volume":"244","author":"Xu","year":"2019","journal-title":"Exp Biol Med (Maywood)"},{"key":"2024121802253982000_33.174.240221.84","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1164\/rccm.201511-2224LE","article-title":"Effect of anti-IL-13 treatment on airway dimensions in severe asthma","volume":"194","author":"Brightling","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2024121802253982000_33.174.240221.85","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S2213-2600(18)30201-7","article-title":"Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial","volume":"6","author":"Russell","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2024121802253982000_33.174.240221.86","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S2213-2600(21)00226-5","article-title":"Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"9","author":"Diver","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2024121802253982000_33.174.240221.87","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00950.2012"},{"key":"2024121802253982000_33.174.240221.88","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1042\/CS20160253","article-title":"Pathogenesis of asthma: implications for precision medicine","volume":"131","author":"Russell Richard","year":"2017","journal-title":"Clin Sci"},{"key":"2024121802253982000_33.174.240221.89","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012705"},{"key":"2024121802253982000_33.174.240221.90","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200409-1220OC"},{"key":"2024121802253982000_33.174.240221.91","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.intimp.2014.05.034","article-title":"Key mediators in the immunopathogenesis of allergic asthma","volume":"23","author":"Hall","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"2024121802253982000_33.174.240221.92","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2015.05.019"},{"key":"2024121802253982000_33.174.240221.93","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01387"},{"key":"2024121802253982000_33.174.240221.94","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-1730"},{"key":"2024121802253982000_33.174.240221.95","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402895"},{"key":"2024121802253982000_33.174.240221.96","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fped.2017.00044","article-title":"The nose and the lung: united airway disease?","volume":"5","author":"Licari","year":"2017","journal-title":"Front Pediatr"},{"key":"2024121802253982000_33.174.240221.97","doi-asserted-by":"publisher","DOI":"10.1177\/039463201402700405"},{"key":"2024121802253982000_33.174.240221.98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.otc.2022.09.001","article-title":"Unified airway disease: a contemporary review and introduction","volume":"56","author":"Fokkens","year":"2023","journal-title":"Otolaryngol Clin North Am"},{"key":"2024121802253982000_33.174.240221.99","doi-asserted-by":"crossref","first-page":"12379","DOI":"10.3390\/ijms241512379","article-title":"Targeting epithelium dysfunction and impaired nasal biofilms to treat immunological, functional, and structural abnormalities of chronic rhinosinusitis","volume":"24","author":"Petalas","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2024121802253982000_33.174.240221.100","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/1744666X.2019.1601556","article-title":"Epithelial physical barrier defects in chronic rhinosinusitis","volume":"15","author":"Jiao","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"2024121802253982000_33.174.240221.101","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/all.16064","article-title":"Updated epithelial barrier dysfunction in chronic rhinosinusitis: targeting pathophysiology and treatment response of tight junctions","volume":"79","author":"Huang","year":"2024","journal-title":"Allergy"},{"key":"2024121802253982000_33.174.240221.102","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaci.2021.03.024","article-title":"Rethinking neutrophils and eosinophils in chronic rhinosinusitis","volume":"148","author":"Delemarre","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"2024121802253982000_33.174.240221.103","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/all.15259","article-title":"Epithelial and sensory mechanisms of nasal hyperreactivity","volume":"77","author":"Velasco","year":"2022","journal-title":"Allergy"},{"key":"2024121802253982000_33.174.240221.104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.04.010"},{"key":"2024121802253982000_33.174.240221.105","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.3390\/ijms21082693","article-title":"Nasal epithelial cells activated with Alternaria and house dust mite induce not only Th2 but also Th1 immune responses","volume":"21","author":"Shin","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2024121802253982000_33.174.240221.106","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/1945892419835333","article-title":"Expression of IL-25, IL-33, and thymic stromal lymphopoietin in nasal polyp gland duct epithelium in patients with chronic rhinosinusitis","volume":"33","author":"Nagata","year":"2019","journal-title":"Am J Rhinol Allergy"},{"key":"2024121802253982000_33.174.240221.107","doi-asserted-by":"crossref","first-page":"2643297","DOI":"10.1155\/2016\/2643297","article-title":"Release of type 2 cytokines by epithelial cells of nasal polyps","volume":"2016","author":"Boita","year":"2016","journal-title":"J Immunol Res"},{"key":"2024121802253982000_33.174.240221.108","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201212-2227OC"},{"key":"2024121802253982000_33.174.240221.109","doi-asserted-by":"crossref","first-page":"E115","DOI":"10.1002\/lary.24462","article-title":"Expression of IL-33 and its receptor ST2 in chronic rhinosinusitis with nasal polyps","volume":"124","author":"Baba","year":"2014","journal-title":"Laryngoscope"},{"key":"2024121802253982000_33.174.240221.110","doi-asserted-by":"publisher","DOI":"10.1002\/alr.21695"},{"key":"2024121802253982000_33.174.240221.111","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jaip.2016.04.015","article-title":"Chronic rhinosinusitis without nasal polyps","volume":"4","author":"Cho","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024121802253982000_33.174.240221.112","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/lary.27815","article-title":"Endoscopic sinus surgery for type-2 CRS wNP: an endotype-based retrospective study","volume":"129","author":"Alsharif","year":"2019","journal-title":"Laryngoscope"},{"key":"2024121802253982000_33.174.240221.113","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.OA2162"},{"key":"2024121802253982000_33.174.240221.114","doi-asserted-by":"crossref","first-page":"e20221212","DOI":"10.1084\/jem.20221212","article-title":"Type 2 inflammation and biological therapies in asthma: targeted medicine taking flight","volume":"220","author":"Howell","year":"2023","journal-title":"J Exp Med"},{"key":"2024121802253982000_33.174.240221.115","doi-asserted-by":"crossref","first-page":"969243","DOI":"10.3389\/fmed.2022.969243","article-title":"Critical evaluation of asthma biomarkers in clinical practice","volume":"9","author":"Guida","year":"2022","journal-title":"Front Med"},{"key":"2024121802253982000_33.174.240221.116","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40733-018-0047-4","article-title":"Biomarkers in asthma: state of the art","volume":"4","author":"Tiotiu","year":"2018","journal-title":"Asthma Res Pract"},{"key":"2024121802253982000_33.174.240221.117","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01033-2018"},{"key":"2024121802253982000_33.174.240221.118","doi-asserted-by":"publisher","DOI":"10.1038\/nm734"},{"key":"2024121802253982000_33.174.240221.119","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5909"},{"key":"2024121802253982000_33.174.240221.120","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fmed.2020.00191","article-title":"Airway remodeling in asthma","volume":"7","author":"Hough","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"2024121802253982000_33.174.240221.121","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.jaci.2019.04.027","article-title":"Blocking histone deacetylase activity as a novel target for epithelial barrier defects in patients with allergic rhinitis","volume":"144","author":"Steelant","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2024121802253982000_33.174.240221.122","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2008.02969.x"},{"key":"2024121802253982000_33.174.240221.123","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2007-0173OC"},{"key":"2024121802253982000_33.174.240221.124","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaci.2019.12.006","article-title":"An expert consensus framework for asthma remission as a treatment goal","volume":"145","author":"Menzies-Gow","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2024121802253982000_33.174.240221.125","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1096\/fj.201801285R","article-title":"IL-13 signaling through IL-13 receptor \u03b12 mediates airway epithelial wound repair","volume":"33","author":"Yang","year":"2019","journal-title":"FASEB J"},{"key":"2024121802253982000_33.174.240221.126","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-6-9"},{"key":"2024121802253982000_33.174.240221.127","doi-asserted-by":"crossref","first-page":"210583","DOI":"10.1183\/13993003.02583-2021","article-title":"Asthma remission: what is it and how can it be achieved","volume":"60","author":"Thomas","year":"2022","journal-title":"Eur Respir J"},{"key":"2024121802253982000_33.174.240221.128","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1016\/j.jaip.2023.07.041","article-title":"Severe Asthma Network Italy definition of clinical remission in severe asthma: a delphi consensus","volume":"11","author":"Canonica","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024121802253982000_33.174.240221.129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.12.1033"},{"key":"2024121802253982000_33.174.240221.130","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01280-2019"},{"key":"2024121802253982000_33.174.240221.131","doi-asserted-by":"publisher","DOI":"10.1177\/1753465810396539"},{"key":"2024121802253982000_33.174.240221.132","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pharmthera.2019.05.002","article-title":"A review on the pathophysiology of asthma remission","volume":"201","author":"Carpaij","year":"2019","journal-title":"Pharm Therap"},{"key":"2024121802253982000_33.174.240221.133","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2023-BTSabstracts.410"},{"key":"2024121802253982000_33.174.240221.134","first-page":"A5995","article-title":"Dupilumab induces clinical remission in patients with uncontrolled, moderate-to-severe, type 2 inflammatory asthma","volume":"207","author":"Pavord","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2024121802253982000_33.174.240221.135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12931-023-02628-7","article-title":"Deep learning prediction of hospital readmissions for asthma and COPD","volume":"24","author":"Lopez","year":"2023","journal-title":"Respir Res"},{"key":"2024121802253982000_33.174.240221.136","first-page":"S-65-74","article-title":"The development of the disease activity score (DAS) and the disease activity score using 28 joint counts (DAS28)","volume":"32","author":"van Riel","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"2024121802253982000_33.174.240221.137","doi-asserted-by":"crossref","first-page":"787128","DOI":"10.3389\/falgy.2021.787128","article-title":"Airway basal cells, protectors of epithelial walls in health and respiratory diseases","volume":"2","author":"Ruysseveldt","year":"2021","journal-title":"Front Allergy"},{"key":"2024121802253982000_33.174.240221.138","doi-asserted-by":"crossref","first-page":"eabj0474","DOI":"10.1126\/sciimmunol.abj0474","article-title":"Tuft cell-produced cysteinyl leukotrienes and IL-25 synergistically initiate lung type 2 inflammation","volume":"6","author":"Ualiyeva","year":"2021","journal-title":"Sci Immunol"},{"key":"2024121802253982000_33.174.240221.139","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aat9453"},{"key":"2024121802253982000_33.174.240221.140","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.11-RAI-0395"},{"key":"2024121802253982000_33.174.240221.141","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.3389\/fimmu.2020.01798","article-title":"Contributions of IL-33 in non-hematopoietic lung cells to obstructive lung disease","volume":"11","author":"Drake","year":"2020","journal-title":"Front Immunol"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0221-2024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:08:18Z","timestamp":1740373698000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0221-2024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":141,"journal-issue":{"issue":"174","published-online":{"date-parts":[[2024,12,18]]},"published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1183\/16000617.0221-2024"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0221-2024","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}